P
Puma Biotechnology, Inc.
PBYI · NASDAQ · Healthcare · 449M
Closing price
$10.29
+3.21% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
16.5×
Price / net assetsP/B
3.9×
Enterprise value / EBITDAEV/EBITDA
9.6×
Free cash flow yieldFCF yield
8.1%
Return on equityROE
23.9%
Operating margin
16.3%
Net debt / EBITDAbalance-sheet strength
-0.0×
Interest coverage
5.6×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.